These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 35595639)

  • 1. Pharmacist-led drug therapy management for hepatitis C at a federally qualified health care center.
    Downes JM; Donovan A; McAdam-Marx C
    J Am Pharm Assoc (2003); 2022; 62(5):1596-1605. PubMed ID: 35595639
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A population approach to disease management: hepatitis C direct-acting antiviral use in a large health care system.
    Belperio PS; Backus LI; Ross D; Neuhauser MM; Mole LA
    J Manag Care Spec Pharm; 2014 Jun; 20(6):533-40. PubMed ID: 24856591
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcomes of Pharmacy-Led Hepatitis C Direct-Acting Antiviral Utilization Management at a Veterans Affairs Medical Center.
    Yang S; Britt RB; Hashem MG; Brown JN
    J Manag Care Spec Pharm; 2017 Mar; 23(3):364-369. PubMed ID: 28230455
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical effectiveness of pharmacist-led versus conventionally delivered antiviral treatment for hepatitis C virus in patients receiving opioid substitution therapy: a pragmatic, cluster-randomised trial.
    Radley A; de Bruin M; Inglis SK; Donnan PT; Hapca A; Barclay ST; Fraser A; Dillon JF
    Lancet Gastroenterol Hepatol; 2020 Sep; 5(9):809-818. PubMed ID: 32526210
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sustained virologic response from hepatitis C from an emergency department screening & linkage program: A retrospective review.
    Walter LA; Wilson L; Farmer M; Roberson T; Hand DT; Franco R
    Am J Emerg Med; 2023 Oct; 72():178-182. PubMed ID: 37540919
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis C virus micro-elimination within a clinic for people with HIV: challenges in the home stretch.
    Hanna J; Sufian J; Suh JS; Jimenez HR
    HIV Med; 2022 Aug; 23(7):801-806. PubMed ID: 35150183
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Barriers to Hepatitis C Virus Care and How Federally Qualified Health Centers Can Improve Patient Access to Treatment.
    Lam D; Wong RJ; Tessier A; Zapata Y; Saldana E; Gish RG
    Gastroenterology Res; 2022 Dec; 15(6):343-352. PubMed ID: 36660471
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatitis C Virus Screening and Care: Complexity of Implementation in Primary Care Practices Serving Disadvantaged Populations.
    Turner BJ; Rochat A; Lill S; Bobadilla R; Hernandez L; Choi A; Guerrero JA
    Ann Intern Med; 2019 Dec; 171(12):865-874. PubMed ID: 31791065
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Developing a multidisciplinary HCV direct-acting antivirals utilization management and assessment program.
    Ajlan AA; Al-Gain R; Ahmed M; Abu-Riash T; Alquaiz M; Alkhail FA; Alashgar H; Alkhairallah T; Alkortas D; Al-Jedai A
    J Am Pharm Assoc (2003); 2021; 61(2):e159-e170. PubMed ID: 33309191
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcomes of a Pharmacist-Led Hepatitis C Virus Treatment Program in an Urban Safety-Net Health System, Chicago, 2017-2019.
    Hunt BR; Cetrone H; Sam S; Glick NR
    Public Health Rep; 2022; 137(4):702-710. PubMed ID: 34043923
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis C Treatment Cascade in a Federally Qualified Health Center.
    Hachey DM; Holmes JT; Aubuchon-Endsley NL
    J Community Health; 2020 Apr; 45(2):264-268. PubMed ID: 31512110
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Providing Hepatitis C Treatment Locally for Substance-Using Patients.
    Clapp SB; Johnson CB
    J Prim Care Community Health; 2023; 14():21501319231186355. PubMed ID: 37424381
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HCV Testing and Treatment in a National Sample of US Federally Qualified Health Centers during the Opioid Epidemic.
    Assoumou SA; Wang J; Nolen S; Eftekhari Yazdi G; Mayer KH; Puro J; Salomon JA; Linas BP
    J Gen Intern Med; 2020 May; 35(5):1477-1483. PubMed ID: 32133577
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reinfection following successful direct-acting antiviral therapy for HCV infection among people attending an inner-city community health centre in Victoria, Canada.
    Selfridge M; Cunningham EB; Barnett T; Drost A; Gray-Schleihauf C; Guarasci K; Lundgren K; Milne R; Grebely J; Fraser C
    Int J Drug Policy; 2021 Oct; 96():103418. PubMed ID: 34538704
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative effectiveness of pharmacist care delivery models for hepatitis C clinics.
    Naidjate SS; Zullo AR; Dapaah-Afriyie R; Hersey ML; Marshall BDL; Winkler RM; Berard-Collins C
    Am J Health Syst Pharm; 2019 May; 76(10):646-653. PubMed ID: 30873537
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Direct-acting antiviral therapy for hepatitis C: The initial experience of the University of Cape Town/Groote Schuur Hospital Liver Clinic, South Africa.
    Sonderup MW; Gogela N; Nordien R; Smuts H; Korsman S; Hardie D; Spearman CW
    S Afr Med J; 2020 Jan; 110(2):112-117. PubMed ID: 32657680
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis C care cascade in a large academic healthcare system, 2012 to 2018.
    Nakayama J; Hertzberg VS; Ho JC; Simpson RL; Cartwright EJ
    Medicine (Baltimore); 2023 Mar; 102(10):e32859. PubMed ID: 36897716
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recently acquired hepatitis C virus infection among people living with human immunodeficiency virus at a university hospital in Taiwan.
    Huang MH; Sun HY; Ho SY; Chang SY; Hsieh SM; Sheng WH; Chuang YC; Huang YS; Su LH; Liu WC; Su YC; Hung CC
    World J Gastroenterol; 2021 Oct; 27(37):6277-6289. PubMed ID: 34712032
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis virus (HCV) diagnosis and access to treatment in a UK cohort.
    Adland E; Jesuthasan G; Downs L; Wharton V; Wilde G; McNaughton AL; Collier J; Barnes E; Klenerman P; Andersson M; Jeffery K; Matthews PC
    BMC Infect Dis; 2018 Sep; 18(1):461. PubMed ID: 30217169
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.